Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.

Shibuya M, Kondo F, Sano K, Takada T, Asano T.

J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):537-43. doi: 10.1007/s00534-010-0365-2.

PMID:
21234612
[PubMed - indexed for MEDLINE]
2.

Morphometric and immunohistochemical study of cholangiolocellular carcinoma: comparison with non-neoplastic cholangiole, interlobular duct and septal duct.

Maeno S, Kondo F, Sano K, Takada T, Asano T.

J Hepatobiliary Pancreat Sci. 2012 May;19(3):289-96. doi: 10.1007/s00534-011-0483-5.

PMID:
22179577
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.

Zhang F, Chen XP, Zhang W, Dong HH, Xiang S, Zhang WG, Zhang BX.

Histopathology. 2008 Jan;52(2):224-32. doi: 10.1111/j.1365-2559.2007.02929.x.

PMID:
18184271
[PubMed - indexed for MEDLINE]
4.

Hepatic progenitor cells in liver cancers from Asian children.

Ward SC, Thung SN, Lim KH, Tran TT, Hong TK, Hoang PL, Jang JJ, Park YN, Abe K.

Liver Int. 2010 Jan;30(1):102-11. doi: 10.1111/j.1478-3231.2009.02126.x. Epub 2009 Sep 28.

PMID:
19793197
[PubMed - indexed for MEDLINE]
5.

Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.

Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, Park YN.

J Hepatol. 2004 Feb;40(2):298-304.

PMID:
14739102
[PubMed - indexed for MEDLINE]
6.

Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.

Yamamoto T, Uenishi T, Ogawa M, Ichikawa T, Hai S, Sakabe K, Tanaka S, Kato H, Mikami S, Ikebe T, Tanaka H, Ito S, Kaneda K, Hirohashi K, Kubo S.

Dig Surg. 2005;22(5):364-70. Epub 2005 Dec 22.

PMID:
16374007
[PubMed - indexed for MEDLINE]
7.

The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.

Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, Lesaffre E, Libbrecht L, Desmet V, Roskams T.

Histopathology. 2006 Aug;49(2):138-51.

PMID:
16879391
[PubMed - indexed for MEDLINE]
8.

Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection.

Okamura D, Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, Miyazaki M.

Mod Pathol. 2008 Jul;21(7):847-55. doi: 10.1038/modpathol.2008.59. Epub 2008 Apr 18.

PMID:
18425081
[PubMed - indexed for MEDLINE]
Free Article
9.

Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.

Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS, Park YN.

Hepatology. 2011 Nov;54(5):1707-17. doi: 10.1002/hep.24559.

PMID:
22045674
[PubMed - indexed for MEDLINE]
10.

Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.

Aishima S, Nishihara Y, Kuroda Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.

Am J Surg Pathol. 2007 May;31(5):783-91.

PMID:
17460464
[PubMed - indexed for MEDLINE]
11.

MRI features of hepatocellular carcinoma expressing progenitor cell markers.

Jeong HT, Kim MJ, Kim YE, Park YN, Choi GH, Choi JS.

Liver Int. 2012 Mar;32(3):430-40. doi: 10.1111/j.1478-3231.2011.02640.x. Epub 2011 Sep 13.

PMID:
22097930
[PubMed - indexed for MEDLINE]
12.

Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.

Abdul-Al HM, Wang G, Makhlouf HR, Goodman ZD.

Int J Surg Pathol. 2010 Oct;18(5):313-8. doi: 10.1177/1066896910364229. Epub 2010 May 5.

PMID:
20444731
[PubMed - indexed for MEDLINE]
13.

The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.

Karabork A, Kaygusuz G, Ekinci C.

Pathol Res Pract. 2010 Aug 15;206(8):572-7. doi: 10.1016/j.prp.2010.03.004. Epub 2010 Apr 18.

PMID:
20400233
[PubMed - indexed for MEDLINE]
14.

Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma.

Brunt EM, Walsh SN, Hayashi PH, Labundy J, Di Bisceglie AM.

Liver Int. 2007 Jun;27(5):662-71.

PMID:
17498252
[PubMed - indexed for MEDLINE]
15.

Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature.

Yoneda N, Matsui O, Kitao A, Kita R, Kozaka K, Koda W, Kobayashi S, Gabata T, Ikeda H, Nakanuma Y.

Jpn J Radiol. 2013 Jul;31(7):480-90. doi: 10.1007/s11604-013-0224-6. Epub 2013 Jun 16.

PMID:
23771695
[PubMed - indexed for MEDLINE]
16.

Progenitor-derived hepatocellular carcinoma model in the rat.

Andersen JB, Loi R, Perra A, Factor VM, Ledda-Columbano GM, Columbano A, Thorgeirsson SS.

Hepatology. 2010 Apr;51(4):1401-9. doi: 10.1002/hep.23488.

PMID:
20054870
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo.

Jabari S, Meissnitzer M, Quint K, Gahr S, Wissniowski T, Hahn EG, Neureiter D, Ocker M.

Int J Oncol. 2009 Jul;35(1):69-80.

PMID:
19513553
[PubMed - indexed for MEDLINE]
18.

[Preliminary research of hepatocarcinoma stem cell markers].

Yan Z, Fang CH, Gao P.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Sep;26(9):1304-6. Chinese.

PMID:
16982441
[PubMed - indexed for MEDLINE]
Free Article
19.

Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.

Cai X, Zhai J, Kaplan DE, Zhang Y, Zhou L, Chen X, Qian G, Zhao Q, Li Y, Gao L, Cong W, Zhu M, Yan Z, Shi L, Wu D, Wei L, Shen F, Wu M.

Hepatology. 2012 Nov;56(5):1804-16. doi: 10.1002/hep.25874. Epub 2012 Jun 25.

PMID:
22684921
[PubMed - indexed for MEDLINE]
20.

Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity.

Sun YL, Yin SY, Xie HY, Zhou L, Xue F, Wu LM, Gao F, Zheng SS.

J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1280-6. doi: 10.1111/j.1440-1746.2008.05342.x. Epub 2008 May 7.

PMID:
18466286
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk